Key Takeaways:
- ELV reported Q2 EPS of $7.45, beating the $6.18 consensus.
- Revenue reached $50.47 billion, topping the $48.45 billion estimate.
- The insurer maintained full-year guidance of $27 per share.
Back
Elevance Health beats Q2 estimates by 20% on $50.5B revenue
Elevance Health Inc. reported Q2 earnings of $7.45 per share, beating the $6.18 consensus by 20.6 percent.
"The results reflect continued execution across our diversified health platform," the Indianapolis-based company said in its earnings release.
Revenue came in at $50.47 billion, or $49.83 billion on an adjusted basis, above the $48.45 billion analysts had expected. Net income was $1.46 billion, compared with $1.94 billion a year earlier when the company earned $8.84 per share.
The health insurer held its full-year outlook at $27 per share. The guidance implies a sharp acceleration from the first half, when the company earned a combined $13.70 per share, suggesting management expects stronger performance in the back half of the year.
Elevance, one of the largest US managed-care companies by membership, operates Blue Cross and Blue Shield plans in 14 states and serves more than 45 million members. The earnings beat comes as the broader managed-care sector faces pressure from rising medical costs and tighter Medicaid reimbursement rates. Rivals UnitedHealth Group Inc. and Humana Inc. have also reported mixed results this earnings season, making Elevance's above-consensus performance a relative bright spot.
The earnings beat signals that Elevance's cost controls and premium pricing are holding up better than peers. Investors will watch the company's investor day later this year for updated margin targets and membership growth forecasts.
This article is for informational purposes only and does not constitute investment advice.
